AlzBiomarker
MCI-AD vs MCI-Stable: Aβ42 (Plasma and Serum)
Baseline levels of plasma Aβ42 did not differ between people with mild cognitive impairment who went on to develop Alzheimer’s dementia and those who did not decline at follow-up. This meta-analysis is limited to five studies.
Loading data...